Background Specific cancer types face specific clinical management challenges. Owing to
their stability, robustness and fast, easy and cost‐effective detection, microRNAs (miRNAs) …

Simple Summary Prostate cancer is a heterogeneous disease and a major cause of cancer
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …

Alzheimer's disease (AD) and cancer have inverse relationship in many aspects. Some
tumor suppressors, including miR‐34c, are decreased in cancer but increased in AD. The …

Improved biomarkers for prostate cancer (PC) risk stratification are urgently needed. Here,
we aimed to develop a novel multimarker model for prediction of biochemical recurrence …

Decreased expression of miR‐142‐3p was observed in human cancers. However, the
function and mechanism of miR‐142‐3p in human colorectal cancer remain obscure. The …

Simple Summary Molecular signatures predictive of recurrence-free survival (RFS) and
castration resistance are critical for treatment decision-making in prostate cancer (PCa), but …

Early detection of prostate cancer (PC) is paramount as localized disease is generally
curable, while metastatic PC is generally incurable. There is a need for improved, minimally …

Within five to ten years after radical prostatectomy (RP), approximately 15–34% of prostate
cancer (PCa) patients experience biochemical recurrence (BCR), which is defined as …

Simple Summary Prostate cancer (PCa) is the most common cancer in men worldwide.
Screening and diagnosis are based on prostate-specific antigen (PSA) blood testing and …

Background: Accumulating evidence shows that the elevated expression of DCBLD2
(discoidin, CUB and LCCL domain-containing protein 2) is associated with unfavorable …